OptimizeRx Corp (OPRX) stock
OPRXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 11/3030% below fair value
$7.34−1.53 (-17.25%)
Close on Nov 13, 2026Market cap $138.26MP/E 28.2Yield –
OptimizeRx total assets
Total assets on the balance sheet at the end of each period.
OptimizeRx's total assets was $162.09M at Sep 30, 2026. For fiscal 2025 it was $176.92M, up 3.4% from the year before. Over ten years it grew 30.5% a year on average. The highest annual figure on record is $183.37M in fiscal 2023.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $176.92M | +3.4% |
| FY2024 | Dec 31, 2024 | $171.17M | -6.7% |
| FY2023 | Dec 31, 2023 | $183.37M | +36.2% |
| FY2022 | Dec 31, 2022 | $134.65M | -4.5% |
| FY2021 | Dec 31, 2021 | $140.99M | +133.7% |
| FY2020 | Dec 31, 2020 | $60.33M | +6.5% |
| FY2019 | Dec 31, 2019 | $56.64M | +126.1% |
| FY2018 | Dec 31, 2018 | $25.05M | +156.6% |
| FY2017 | Dec 31, 2017 | $9.76M | -14.9% |
| FY2016 | Dec 31, 2016 | $11.48M | -6.8% |
| FY2015 | Dec 31, 2015 | $12.31M | +75.2% |
| FY2014 | Dec 31, 2014 | $7.03M | +77.8% |
| FY2013 | Dec 31, 2013 | $3.95M | +81.7% |
| FY2012 | Dec 31, 2012 | $2.18M | -24.8% |
| FY2011 | Dec 31, 2011 | $2.89M | -22.8% |
| FY2010 | Dec 31, 2010 | $3.75M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $162.09M | -4.8% |
| Q2 FY2026 | Jun 30, 2026 | $164.32M | -2.9% |
| Q1 FY2026 | Mar 31, 2026 | $167.26M | -0.3% |
| Q4 FY2025 | Dec 31, 2025 | $176.92M | +3.4% |
| Q3 FY2025 | Sep 30, 2025 | $170.32M | +3.1% |
| Q2 FY2025 | Jun 30, 2025 | $169.27M | -2.1% |
| Q1 FY2025 | Mar 31, 2025 | $167.77M | -4.9% |
| Q4 FY2024 | Dec 31, 2024 | $171.17M | -6.7% |
| Q3 FY2024 | Sep 30, 2024 | $165.20M | +33.3% |
| Q2 FY2024 | Jun 30, 2024 | $172.88M | +42.5% |
| Q1 FY2024 | Mar 31, 2024 | $176.37M | +33.9% |
| Q4 FY2023 | Dec 31, 2023 | $183.37M | +36.2% |
| Q3 FY2023 | Sep 30, 2023 | $123.93M | -8.8% |
| Q2 FY2023 | Jun 30, 2023 | $121.32M | -12.2% |
| Q1 FY2023 | Mar 31, 2023 | $131.69M | -6.6% |
| Q4 FY2022 | Dec 31, 2022 | $134.65M | +0.0% |
| Q3 FY2022 | Sep 30, 2022 | $135.87M | +3.2% |
| Q1 FY2022 | Mar 31, 2022 | $138.14M | +8.3% |
| Q4 FY2021 | Dec 31, 2021 | $140.99M | +133.7% |
| Q3 FY2021 | Sep 30, 2021 | $134.65M | +144.2% |
| Q2 FY2021 | Jun 30, 2021 | $131.62M | +134.8% |
| Q1 FY2021 | Mar 31, 2021 | $127.57M | +126.9% |
| Q4 FY2020 | Dec 31, 2020 | $60.33M | +6.5% |
| Q3 FY2020 | Sep 30, 2020 | $55.15M | +11.1% |
| Q2 FY2020 | Jun 30, 2020 | $56.06M | +121.9% |
| Q1 FY2020 | Mar 31, 2020 | $56.24M | +124.5% |
| Q4 FY2019 | Dec 31, 2019 | $56.64M | +186.6% |
| Q2 FY2019 | Jun 30, 2019 | $49.64M | +166.2% |
| Q1 FY2019 | Mar 31, 2019 | $25.26M | +172.4% |
| Q4 FY2018 | Dec 31, 2018 | $25.05M | +156.6% |
| Q3 FY2018 | Sep 30, 2018 | $19.76M | +101.3% |
| Q2 FY2018 | Jun 30, 2018 | $18.64M | +77.9% |
| Q1 FY2018 | Mar 31, 2018 | $9.27M | -15.1% |
| Q4 FY2017 | Dec 31, 2017 | $9.76M | -14.9% |
| Q3 FY2017 | Sep 30, 2017 | $9.81M | -12.8% |
| Q2 FY2017 | Jun 30, 2017 | $10.48M | -4.7% |
| Q1 FY2017 | Mar 31, 2017 | $10.93M | – |
| Q4 FY2016 | Dec 31, 2016 | $11.48M | – |
| Q3 FY2016 | Sep 30, 2016 | $11.26M | – |
| Q2 FY2016 | Jun 30, 2016 | $11.00M | – |
See a number that looks wrong?